Related Experiment Video
Updated: Jan 11, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Cross-ethnic Molecular Signatures Underpin the Adverse Impact of Statin Use on Type 2 Diabetes
Fengzhe Xu1, Min Yang1, Wei Hu2
1Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China.
Abstract:
The use of statins as the primary therapy for reducing low-density lipoprotein cholesterol has raised concerns regarding their potential side effects in increasing the risk of type 2 diabetes (T2D). However, the underlying mechanism remains largely unknown. In this study, we utilized multi-omics molecular signatures to unravel the etiology of statin-induced T2D. Through systematic screening of 102 gut microbial features, 40 blood metabolites, and 131 circulating proteins in East Asians and Europeans, we identified a set of blood metabolites and proteins potentially influenced by genetically proxied statin use. Notably, Mendelian randomization analyses provided evidence that elevated circulating levels of gastric inhibitory polypeptide (GIP) were associated with an increased risk of T2D. This association between genetically proxied statin use and GIP was consistently observed across East Asian and European populations, highlighting the pivotal role of GIP in modulating the risks of statin-induced T2D. Furthermore, this study established an extensive atlas of multi-omics molecular signatures associated with statin-induced T2D, offering valuable insights for prioritizing intervention targets.
Insights
Statins may increase type 2 diabetes (T2D) risk. This study found elevated gastric inhibitory polypeptide (GIP) levels, linked to statin use, may explain this T2D risk in diverse populations.
Area of Science:
- Genetics and Molecular Biology
- Metabolomics and Proteomics
- Endocrinology and Diabetes Research
Background:
- Statins are primary therapies for lowering LDL cholesterol but are associated with an increased risk of type 2 diabetes (T2D).
- The precise mechanisms underlying statin-induced T2D remain largely unidentified, necessitating further investigation into molecular pathways.
- Understanding these mechanisms is crucial for mitigating adverse effects and optimizing lipid-lowering therapies.
Purpose of the Study:
- To elucidate the molecular etiology of statin-induced type 2 diabetes (T2D) using a multi-omics approach.
- To identify specific metabolites and proteins influenced by statin use that may contribute to T2D risk.
- To investigate the role of gastric inhibitory polypeptide (GIP) in the association between statin use and T2D.
Main Methods:
- Systematic screening of gut microbial features, blood metabolites, and circulating proteins in East Asian and European cohorts.
- Utilized Mendelian randomization analyses to assess causal relationships between genetically proxied statin use, molecular signatures, and T2D risk.
- Integrated multi-omics data to establish molecular signatures associated with statin-induced T2D.
Main Results:
- Identified a panel of blood metabolites and proteins potentially affected by genetically proxied statin use across different ethnicities.
- Mendelian randomization analysis revealed a significant association between elevated circulating gastric inhibitory polypeptide (GIP) levels and increased T2D risk.
- The link between genetically proxied statin use and GIP was consistent in both East Asian and European populations, underscoring GIP's role.
Conclusions:
- Gastric inhibitory polypeptide (GIP) plays a key role in mediating the risk of type 2 diabetes associated with statin therapy.
- This study provides a comprehensive multi-omics atlas of molecular signatures linked to statin-induced T2D.
- The findings offer valuable insights for identifying potential therapeutic targets to prevent or manage statin-associated T2D.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Psychoneuroimmunology: Diabetes and Cancer

